·Confidence 75%
Zhengye Biotechnology Meets Nasdaq Compliance, Shares Decline
Key takeaways
- Zhengye Biotechnology has regained compliance with Nasdaq's bid price requirements, yet its shares have experienced a decline following the announcement.
Analysis
Zhengye Biotechnology has regained compliance with Nasdaq's bid price requirements, yet its shares have experienced a decline following the announcement.
0 likes · 0 dislikes